ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Anixa Biosciences Inc
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026
$2.61−0.06 (-2.25%)
Close on Oct 19, 2026
- Market cap
- $89.22M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Anixa Biosciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jul 31, 2026 | Sep 9, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Apr 30, 2026 | Jun 10, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 9, 2026 | Feb 9, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 28, 2026 | Jan 28, 2026 | SEC EDGAR |
| Annual report | 10-K | Oct 31, 2025 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2025 | Sep 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Apr 30, 2025 | May 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2025 | Mar 21, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2025 | Mar 11, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 31, 2024 | Feb 6, 2025 | SEC EDGAR |
| Annual report | 10-K | Oct 31, 2024 | Jan 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 8, 2024 | Nov 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2024 | Sep 6, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Apr 30, 2024 | Jun 4, 2024 | SEC EDGAR |
| Current report | 8-K | May 3, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2024 | Mar 22, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2024 | Mar 12, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Feb 8, 2024 | Feb 8, 2024 | SEC EDGAR |
| Annual report | 10-K | Oct 31, 2023 | Jan 16, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 6, 2023 | Dec 7, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2023 | Sep 6, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Apr 30, 2023 | Jun 14, 2023 | SEC EDGAR |
| Current report | 8-K | Apr 17, 2023 | Apr 17, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2023 | Mar 17, 2023 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2023 | Mar 10, 2023 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 27, 2023 | Jan 27, 2023 | SEC EDGAR |
| Annual report | 10-K | Oct 31, 2022 | Jan 4, 2023 | SEC EDGAR |
| Current report | 8-K | Dec 8, 2022 | Dec 8, 2022 | SEC EDGAR |
| Current report | 8-K | Sep 28, 2022 | Sep 29, 2022 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2022 | Sep 9, 2022 | SEC EDGAR |
| Current report | 8-K | Aug 15, 2022 | Aug 17, 2022 | SEC EDGAR |
| Quarterly report | 10-Q | Apr 30, 2022 | Jun 10, 2022 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2022 | Apr 15, 2022 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2022 | Mar 11, 2022 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2022 | Mar 11, 2022 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 28, 2022 | Jan 28, 2022 | SEC EDGAR |
| Annual report | 10-K | Oct 31, 2021 | Jan 4, 2022 | SEC EDGAR |